Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 3
1958 1
1959 1
1961 1
1962 2
1963 4
1964 4
1965 2
1966 2
1967 5
1968 1
1969 4
1970 5
1971 2
1973 3
1974 2
1975 1
1976 4
1977 3
1978 3
1979 3
1980 2
1981 6
1982 4
1983 7
1984 5
1985 9
1986 16
1987 9
1988 4
1989 11
1990 9
1991 9
1992 14
1993 13
1994 8
1995 13
1996 23
1997 19
1998 20
1999 23
2000 18
2001 19
2002 16
2003 15
2004 19
2005 28
2006 28
2007 30
2008 42
2009 36
2010 39
2011 29
2012 39
2013 33
2014 36
2015 40
2016 39
2017 39
2018 34
2019 30
2020 30
2021 34
2022 39
2023 44
2024 42

Text availability

Article attribute

Article type

Publication date

Search Results

972 results

Results by year

Filters applied: . Clear all
Page 1
Six-month outcomes of switching from aflibercept to faricimab in refractory cases of neovascular age-related macular degeneration.
Kataoka K, Itagaki K, Hashiya N, Wakugawa S, Tanaka K, Nakayama M, Yamamoto A, Mukai R, Honjyo J, Maruko I, Kawai M, Miyara Y, Terao N, Wakatsuki Y, Onoe H, Mori R, Koizumi H, Sekiryu T, Iida T, Okada AA; for Japan AMD Research Consortium (JARC). Kataoka K, et al. Among authors: koizumi h. Graefes Arch Clin Exp Ophthalmol. 2024 Jan;262(1):43-51. doi: 10.1007/s00417-023-06222-x. Epub 2023 Sep 5. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 37668741
Efficacy, durability, and safety of faricimab up to every 16 weeks in patients with neovascular age-related macular degeneration: 1-year results from the Japan subgroup of the phase 3 TENAYA trial.
Mori R, Honda S, Gomi F, Tsujikawa A, Koizumi H, Ochi H, Ohsawa S, Okada AA; TENAYA and LUCERNE Investigators. Mori R, et al. Among authors: koizumi h. Jpn J Ophthalmol. 2023 May;67(3):301-310. doi: 10.1007/s10384-023-00985-w. Epub 2023 Apr 11. Jpn J Ophthalmol. 2023. PMID: 37039948 Free PMC article. Clinical Trial.
INCIDENCE AND RISK FACTORS OF INTRAOCULAR INFLAMMATION AFTER BROLUCIZUMAB TREATMENT IN JAPAN: A Multicenter Age-Related Macular Degeneration Study.
Inoda S, Takahashi H, Maruyama-Inoue M, Ikeda S, Sekiryu T, Itagaki K, Matsumoto H, Mukai R, Nagai Y, Ohnaka M, Kusuhara S, Miki A, Okada AA, Nakayama M, Nishiguchi KM, Takeuchi J, Mori R, Tanaka K, Honda S, Kohno T, Koizumi H, Miyara Y, Inoue Y, Takana H, Iida T, Maruko I, Hayashi A, Ueda-Consolvo T, Yanagi Y. Inoda S, et al. Among authors: koizumi h. Retina. 2024 Apr 1;44(4):714-722. doi: 10.1097/IAE.0000000000004009. Retina. 2024. PMID: 38016089
Relationship between Pachychoroid and Polypoidal Choroidal Vasculopathy.
Yamashiro K, Yanagi Y, Koizumi H, Matsumoto H, Cheung CMG, Gomi F, Iida T, Tsujikawa A. Yamashiro K, et al. Among authors: koizumi h. J Clin Med. 2022 Aug 8;11(15):4614. doi: 10.3390/jcm11154614. J Clin Med. 2022. PMID: 35956229 Free PMC article. Review.
MEFV variants are a predisposing factor for generalized pustular psoriasis.
Yoshikawa T, Takeichi T, Nishida K, Kobayashi Y, Sano H, Shibata A, Koizumi H, Tsutsumi R, Fukaura R, Hayashi M, Imanishi A, Nakamura K, Mikoshiba Y, Ogawa E, Sano S, Kinoshita M, Okamoto T, Kageyama R, Sano Y, Kaneko S, Aoi J, Hara T, Togawa Y, Kishibe M, Yoshida Y, Yagi H, Honda T, Sugiura K, Sano S, Suzuki T, Ogi T, Muro Y, Akiyama M. Yoshikawa T, et al. Among authors: koizumi h. J Am Acad Dermatol. 2024 Apr;90(4):852-854. doi: 10.1016/j.jaad.2023.10.070. Epub 2023 Dec 19. J Am Acad Dermatol. 2024. PMID: 38128830 Free article. No abstract available.
Dendritic Remodeling: Lessons from Invertebrate Model Systems.
Kanamori T, Togashi K, Koizumi H, Emoto K. Kanamori T, et al. Among authors: koizumi h. Int Rev Cell Mol Biol. 2015;318:1-25. doi: 10.1016/bs.ircmb.2015.05.001. Epub 2015 Jun 4. Int Rev Cell Mol Biol. 2015. PMID: 26315882 Review.
Bonding of resin luting materials to titanium and titanium alloy.
Kodaira A, Koizumi H, Hiraba H, Takeuchi Y, Koike M, Shimoe S. Kodaira A, et al. Among authors: koizumi h. J Oral Sci. 2022 Jul 1;64(3):181-184. doi: 10.2334/josnusd.22-0036. Epub 2022 May 18. J Oral Sci. 2022. PMID: 35584941 Free article. Review.
972 results